Gender dysphoria in children: puberty blockers study draws further criticism

@article{Cohen2019GenderDI,
  title={Gender dysphoria in children: puberty blockers study draws further criticism},
  author={Deborah Anne Cohen and Hannah Barnes},
  journal={BMJ},
  year={2019},
  volume={366}
}
An opportunity to strengthen the evidence base for these treatments in a particularly vulnerable group of patients may have been missed, say Deborah Cohen and Hannah Barnes, who catalogue new concerns about NHS research practices and decisions to lower the minimum age for treatment before results were published 
Gender dysphoria: a question of informed consent
TLDR
Although the Health Research Authority’s investigation concluded that researchers did not veer from research norms, the authors are left with important questions over their use.
Gender dysphoria: scientific oversight falling between responsible institutions should worry us all
The troubles around the Gender Identity Development Service’s study12 seem to be symptomatic of our wider collective failure to determine whether, and when, we should prescribe puberty blockers, or
Gender dysphoria: puberty blockers and loss of bone mineral density
Cohen and Barnes clearly articulate the ongoing debate on the effects of puberty blockers (gonadotrophin releasing hormone (GnRH) agonists) on bone mineral density in trans and gender diverse young
Authors’ reply to Shaw
TLDR
Shaw fails to recognise why journalists have been drawn into reporting on interventions and research in transgender health, and has a duty to examine claims that are brought to us that are of significant public interest.
Gender dysphoria researchers did not veer from research norms, says ethics review
TLDR
The UK Health Research Authority has concluded that the team carrying out a controversial study offering puberty blockers to adolescents with gender dysphoria worked in accordance with recognised practice for health research and, in some areas, were ahead of normal practice at the time.
Extreme ‘gender critical’ views will alienate many gender dysphoric patients
TLDR
The journal editor stated that the original conclusion of the benefits of surgeries ‘was too strong’, and the data ‘demonstrated no advantage of surgery in relation to subsequent mood or anxiety disorder-related health care visits or prescriptions or hospitalizations following suicide attempts’.
Sex, gender and gender identity: a re-evaluation of the evidence
TLDR
The authors consider the uncertainties that clinicians face when dealing with something that is no longer a disorder nor a mental condition and yet for which medical interventions are frequently sought and in which mental health comorbidities are common.
Gender reassignment: High Court to say whether NHS guidance on hormone blockers can be legally challenged
The High Court in London has been asked to give the go ahead for a challenge to the legality of NHS guidelines on administering hormone blocking drugs to children at the UK’s only specialist NHS
Gender Dysphoria Treatment: A Critical Discussion of Medical and Psychotherapeutic Approaches in Adults and Young People
Gender Dysphoria focuses on the psychological state at which individuals experience low levels of perceived satisfaction regarding their primary and secondary physiological traits, their biological
Gender dysphoria: same old media tropes
TLDR
Rather than shedding light on the relevant sociopolitical, ethical, and scientific issues, Cohen and Barnes seem to view the complexity of gender dysphoria in adolescence through a narrow media lens.
...
1
2
...

References

SHOWING 1-10 OF 21 REFERENCES
Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
INTRODUCTION Puberty suppression by means of gonadotropin-releasing hormone analogues (GnRHa) is used for young transsexuals between 12 and 16 years of age. The purpose of this intervention is to
The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort
TLDR
There was no significant change in the absolute values of hip or spine BMD or lumbar spine BMAD after 1 year on GnRHa and a lower fall in BMD/BMAD Z-scores in the longitudinal group in the second year, suggesting long-term BMD recovery studies on sex hormone treatment are needed.
American psychiatric association.
  • W. Alexander
  • Psychology, Medicine
    P & T : a peer-reviewed journal for formulary management
  • 2008
TLDR
Among studies of post-traumatic stress disorder in veterans returning from tours of duty in Iraq, preliminary results for medications in combination with virtual reality exposure therapy show strong promise.
Inventing transgender children and young people
  • 2019
An open letter to Dr Polly Carmichael from a former GIDS clinician
Board of directors part one: agenda and papers of a meeting to be held in public
Body image and mental health. House of Commons official record (Hansard)
For permission to use (where not already granted under a licence
  • See rights and reprints
...
1
2
3
...